The heart scars, but does not regenerate

Cardiovascular diseases remain the leading cause of mortality worldwide, with myocardial infarction (MI) representing one of the main drivers of progression toward heart failure. The abrupt and irreversible loss of cardiomyocytes, combined with vascular disruption, triggers a cascade of events that culminates in fibrotic scar formation, permanently impairing the contractile function of the myocardium.

Despite significant advances in pharmacological therapies, assistive devices, and surgical interventions, no current strategy is capable of fully restoring the structural and functional integrity of cardiac tissue. The limited regenerative capacity of the adult myocardium, with cardiomyocyte turnover rates estimated at only 0.3 to 1 percent per year, highlights a fundamental gap in cardiovascular regenerative medicine.

Post-infarction remodeling from necrosis to fibrosis

Cardiac remodeling following myocardial infarction is a dynamic and highly regulated process that can be broadly divided into three phases: necrosis, fibrosis, and remodeling.

The initial phase is characterized by cardiomyocyte death and degradation of the extracellular matrix, driven by increased matrix metalloproteinase activity and loss of structural glycoproteins. This results in transient ventricular compliance and disruption of tissue architecture.

During the fibrotic phase, cardiac fibroblasts become activated and differentiate into myofibroblasts under the influence of mediators such as TGF beta. These cells secrete large amounts of extracellular matrix, with predominant deposition of collagen types I and III, leading to increased tissue stiffness and altered mechanical anisotropy.

In the remodeling phase, the scar undergoes structural reorganization, with increased collagen crosslinking and progressive changes in global mechanical properties. While this process stabilizes the ventricular wall, it ultimately results in the formation of a non contractile and functionally compromised tissue.

The extracellular matrix as a regulator of the cardiac microenvironment

Under physiological conditions, the cardiac extracellular matrix plays a central role in maintaining tissue homeostasis. In addition to providing structural support, it functions as a dynamic signaling platform that regulates cell adhesion, alignment, differentiation, and electromechanical coupling.

This matrix is composed of a highly organized three dimensional network rich in collagen, fibronectin, laminin, proteoglycans, and matricellular proteins. These components not only support the tissue mechanically but also modulate the availability of growth factors and inflammatory responses.

Following myocardial infarction, this organization is profoundly disrupted. The extracellular matrix undergoes initial degradation followed by rapid and unbalanced collagen deposition, accompanied by reduced proteomic diversity and loss of structural organization. As a result, the microenvironment becomes mechanically stiff and biologically restrictive.

The fibrotic scar therefore should not be interpreted merely as a structural replacement, but as a microenvironment that is insufficient to support effective regeneration.

Limitations of current regenerative strategies

Cell based therapies have been extensively explored as potential approaches for myocardial repair. However, challenges such as low cell retention, limited integration with host tissue, and reduced post implantation survival remain significant barriers.

These limitations suggest that therapeutic success is not determined solely by the choice of cell type, but also by the microenvironment into which these cells are introduced.

In the absence of a functional extracellular matrix capable of providing appropriate biochemical and biomechanical cues, the ability of cells to survive, organize, and contribute to tissue function remains severely compromised.

Extracellular matrix proteomic complexity evidence from QMatrix

The extracellular matrix is inherently a highly complex system composed of a wide range of structural proteins, adhesion glycoproteins, and matricellular components involved in the regulation of signaling pathways.

This complexity is often underrepresented in conventional biomaterials, which typically rely on synthetic polymers or isolated components, resulting in biologically simplified systems.

In this context, the characterization of extracellular matrix derived materials becomes particularly relevant.

Proteomic analysis of QMatrix reveals a diverse set of proteins associated with structural organization, cell adhesion, and matrix regulation. This diversity supports the presence of a multifaceted molecular environment that more closely reflects native extracellular matrix composition.

Complementarily, SDS PAGE analysis stained with Fast Blue demonstrates a consistent protein banding pattern across different samples. Rather than serving as a method for protein identification, this analysis supports the reproducibility of the protein profile, indicating robustness and consistency in the production process.

Together, these data suggest that QMatrix combines molecular complexity with process reliability, both of which are critical parameters for the development of extracellular matrix based platforms in regenerative medicine.

Reintroducing complexity into the post infarction microenvironment

Given that the fibrotic scar is characterized by a collagen dominant matrix with reduced proteomic diversity and increased stiffness, the introduction of more complex extracellular matrix based materials may represent a strategy to modulate the post infarction microenvironment.

This approach goes beyond providing structural support.

It involves reintroducing biochemical and biophysical cues capable of influencing cell behavior.

Extracellular matrix derived materials have been associated with enhanced paracrine signaling, promotion of vascularization, and modulation of inflammatory responses, while also supporting cell adhesion and tissue organization.

Within this framework, materials such as QMatrix can be interpreted as biologically active platforms capable of restoring part of the molecular complexity required to support more effective repair processes.

Final considerations

Post infarction remodeling is an inevitable process, but it is not optimized for functional regeneration. While fibrotic scar formation preserves structural integrity, it compromises both mechanical performance and biological functionality.

The growing understanding of the extracellular matrix as a central regulator of the cardiac microenvironment suggests that regenerative strategies must extend beyond cell replacement and incorporate approaches capable of restoring extracellular matrix complexity.

In this context, a fundamental question remains:

Is it possible to achieve effective cardiac regeneration without reconstructing the extracellular microenvironment that sustains myocardial function?

About the author

Gabriela Morais holds a degree in Mechanical Engineering from UFMA and a Master’s degree in Biomedical Engineering from UFABC. She is currently the Innovation Coordinator at Quantis Biotechnology. Her work focuses on the design and development of technological processes for the production of human extracellular matrix, with an emphasis on bioprocess optimization, purification, and scale-up. Her expertise includes biofabrication, biomaterials characterization, and the development of ECM-based platforms for applications in Tissue Engineering and Regenerative Medicine.